Diabetic Macular Edema News and Research

RSS
Fluid can leak into the center of the macula, the part of the eye where sharp, straight-ahead vision occurs. The fluid makes the macula swell, blurring vision. This condition is called macular edema. It can occur at any stage of diabetic retinopathy, although it is more likely to occur as the disease progresses. About half of the people with proliferative retinopathy also have macular edema.
New treatment targeting aging cells could offer lasting relief for diabetic macular edema

New treatment targeting aging cells could offer lasting relief for diabetic macular edema

Falk Trust awards $1.35 million to Case Western Reserve researchers for cancer and diabetic retinopathy treatments

Falk Trust awards $1.35 million to Case Western Reserve researchers for cancer and diabetic retinopathy treatments

The role of caffeine in preventing diabetic retinopathy

The role of caffeine in preventing diabetic retinopathy

Early treatment of diabetes-related eye disease does not improve visual acuity

Early treatment of diabetes-related eye disease does not improve visual acuity

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

AI could predict treatment demand for chronic eye diseases

AI could predict treatment demand for chronic eye diseases

Early treatment with anti-VEGF injections slows diabetic retinopathy

Early treatment with anti-VEGF injections slows diabetic retinopathy

New mobile app can help people diagnosed with glaucoma

New mobile app can help people diagnosed with glaucoma

Common medication used to treat diabetic macular edema is less effective in Black patients

Common medication used to treat diabetic macular edema is less effective in Black patients

Phase 2 clinical trial to examine the effects of razuprotafib on COVID-19 patients

Phase 2 clinical trial to examine the effects of razuprotafib on COVID-19 patients

New eye drops could prevent vision loss after retinal vein occlusion

New eye drops could prevent vision loss after retinal vein occlusion

Preclinical data of Ocugen's OCU400 genetic modifier published in Nature Gene Therapy

Preclinical data of Ocugen's OCU400 genetic modifier published in Nature Gene Therapy

Helper protein exacerbates diabetic macular edema

Helper protein exacerbates diabetic macular edema

Retinal macular damage linked to sleep apnea in diabetes

Retinal macular damage linked to sleep apnea in diabetes

Sleep apnea is a risk factor for developing diabetic macular edema, study shows

Sleep apnea is a risk factor for developing diabetic macular edema, study shows

Inflammasome, Boehringer Ingelheim team up to develop new therapies for retinal diseases

Inflammasome, Boehringer Ingelheim team up to develop new therapies for retinal diseases

HbA1c analyzer identifies diabetics with poor glycemic control and high risk of sight loss

HbA1c analyzer identifies diabetics with poor glycemic control and high risk of sight loss

A new strategy for managing diabetic macular edema in people with good vision

A new strategy for managing diabetic macular edema in people with good vision

Experimental drug may be twice as good at fighting vision loss as previously thought

Experimental drug may be twice as good at fighting vision loss as previously thought

New cellular atlas could provide a deeper insight into blinding diseases

New cellular atlas could provide a deeper insight into blinding diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.